{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-038728","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2026-10-06T12:05:36+00:00","discovered_at":"2026-10-06T12:10:00.363138+00:00","generated_at":"2026-10-12T16:33:24.784966+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"PDS Biotech to Host Oct. 15 KOL Event on PDS0301 in Metastatic Colorectal Cancer","bullets":["PDS Biotechnology (Nasdaq: PDSB) will host a virtual KOL event on October 15, 2026, at 8:00 AM ET featuring NCI/CCR investigator Jonathan M. Hernandez, M.D.","Event covers clinical outcomes from PDS0301 Phase 2 trials in advanced liver-associated cancers, focusing on the metastatic colorectal cancer (mCRC) cohort.","PDS0301 is an investigational IL-12 immunocytokine designed to bind necrotic DNA in tumors and deliver IL-12 to promote T cell and NK cell infiltration.","Trial population includes second- and third-line unresectable microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal liver metastases, the majority of mCRC."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-038728","json":"https://secwatch.observer/filing/0001140361-26-038728.json","markdown":"https://secwatch.observer/filing/0001140361-26-038728.md","text":"https://secwatch.observer/filing/0001140361-26-038728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126038728/0001140361-26-038728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126038728/ef20083341_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:33:24.784966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}